Imaging Biomarkers in Clinical Trials:
Current Practice & Future Trends
2015 Dates Coming Soon

Imaging biomarkers serve as important endpoints for clinical trials in the approval process for therapeutic drugs. Various criteria have been developed for objective interpretation of imaging studies. Additionally, there are emerging imaging techniques that have the potential for applications as surrogate endpoints for clinical trials. In this program, we will review the current practice of imaging biomarkers in clinical trials in oncology. Additionally, we will highlight advanced imaging techniques that have potential as surrogate biomarkers.

Back to Top